Clinical Trial Update: Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated Adults [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and immunogenicity of the AERAS-402 TB vaccine in HIV-infected, BCG-vaccinated adults; results were posted after study completio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Tuberculosis

Drugs mentioned

• AERAS-402

Snippet

Sponsor: Aeras | Conditions: Tuberculosis, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-10-13